Uroplasty, Inc. (AMEX: UPI), a global medical device company, is focused on developing, manufacturing, and marketing products for the minimally invasive treatment of voiding dysfunctions and pelvic disorders. The company offers a wide range of products that meet the demands of healthcare professionals and patients. Their devices help healthcare professionals increase the efficiency of their treatment options while reducing patient risk. For further information, visit the Company’s web site at www.uroplasty.com.
- 17 years ago
QualityStocks
Uroplasty, Inc. (AMEX: UPI)
Tags Rodman & Renshaw
Related Post
-
QualityStocksNewsBreaks – American Fusion Inc. (OTC: AMFN) Secures Court Order To Cancel 1.68 Billion Improperly Issued Shares
American Fusion (OTC: AMFN) announced it obtained a default judgment from the Superior Court of…
-
QualityStocksNewsBreaks – LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) (FSE: 3WK0) Files NI 43-101 Technical Report Supporting Swanson Gold Project PEA
This article has been disseminated on behalf of LaFleur Minerals and may include paid advertising.…
-
LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) Executives Outline Positive PEA Results Plus Company’s Next Steps to Production in Investor Webinar
Disseminated on behalf of LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) and may include paid…